|||
1 | Recruiting | Respiratory Virus Hospitalization Study (FLU 003 Plus)
| ||||
2 | Active, not recruiting | Anti-MERS-COV Convalescent Plasma Therapy
| ||||
3 | Recruiting | Respiratory Virus Outpatient Study (FLU 002 Plus)
| ||||
4 | Enrolling by invitation | Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases
| ||||
5 | Completed Has Results | Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
|
https://clinicaltrials.gov/ct2/results?term=middle+east+respiratory+syndrome
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-5-27 10:55
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社